Myocardial fibrosis found on CMR in patients with hypertension associated with worse outcomes Dr. Kamal Kant Kohli8 Aug 2022 2:30 PM GMTA recent study conducted by the National Heart Centre Singapore (NHCS) discovered that myocardial fibrosis is associated with worse cardiovascular...
Hypertension control in Kerala, India: a prescription-based study Dr. Nandita Mohan17 Jun 2022 4:30 AM GMTA prescription-based study was conducted to identify the provider and institution-level factors related to achieving guideline-recommended control of...
Aprocitentan found efficacious in patients with resistant hypertension in Phase 3 study Dr. Kamal Kant Kohli26 May 2022 2:15 PM GMTAprocitentan is an investigational, oral, dual endothelin receptor antagonist designed to potently inhibit the binding of endothelin-1 (ET-1) to ETA...
Time in target range TTR in the field of hypertension management Dr.B.P.RAHUL19 May 2022 12:30 PM GMTHypertension is one of the most common comorbidities and risk factors for cardiovascular disease including heart failure (HF). However, standard BP...
